Mucopolysaccharidoses Patient's Transition To Adulthood

A 30-minute webinar with Dr Christina Lampe (Director, Rare Disease Centre, Gießen) on the transition of mucopolysaccharidosis (MPS) patients from paediatric to adult care — the structural, emotional and clinical gaps, and international models for bridging them. For paediatricians and metabolic teams.

Recorded on:
June 24, 2020
30 minutes
English
MPSEU2M6
This webinar is intended for healthcare professionals only. The views and opinions expressed are those of the presenting experts and are their own; their inclusion on the Excellence in Pediatrics (EiP) website does not imply that EiP endorses, agrees or disagrees with them. Any patient images, clinical photographs or case details shown are the responsibility of the presenting experts, who confirm that the necessary consent and approvals were obtained — their inclusion in the presentation indicates that such approval is in place. This webinar was organised on behalf of MPS Europe and received no industry sponsorship or funding. The content is provided for educational purposes only and does not constitute medical advice or replace independent clinical judgement.

Summary

As treatment lets more children with MPS reach adulthood, transition — a purposeful, planned process addressing the medical, psychosocial and educational needs of adolescents moving from child-centred to adult-oriented care — has become essential. Dr Christina Lampe contrasts the two care models: paediatric care is family-centred, holistic, protective and development-focused, while adult care emphasises independence, patient responsibility and compartmentalised specialist input, and many adult providers lack training in adolescent medicine — leaving a gap precisely where adolescents (a wide span of developmental stages) need continuity most. Drawing on European MetabERN surveys, she documents the deficits: only about 11% of respondents were adult metabolic physicians, nearly 20% of patients never transition (continuing lifelong with paediatricians), and there is a widespread lack of transition coordinators, standardised documentation and financial support. She reviews successful international models — France's 'Jump' programme and a US six-step system, both starting around age 12 and introducing adult services gradually over years — and stresses that transition is a long, planned process, not an event at 18. In MPS specifically, two groups need different approaches: cognitively intact patients, who can pursue independence, work, relationships and family planning ('I'm different, but I want a normal life'), and cognitively involved patients, who depend on their families, are sensitive to changes of environment, and need sustained, sensitive support including end-of-life planning — while both need continued monitoring of progressive somatic complications and, as adults, care for ordinary adult conditions. Her recommendations: plan early, educate and engage both patients and adult teams, involve adult physicians before transfer, give young people time to be seen without their parents, appoint a coordinator (not necessarily a physician), document the process in a standardised way, involve families, and keep every plan individualised and flexible.

Learning Objectives

After viewing this webinar, participants will be able to:

  • Define transition and explain why it matters as more MPS patients reach adulthood.
  • Contrast the paediatric and adult models of care and identify the gaps adolescents fall into.
  • Summarise the European (MetabERN) survey findings on the deficits in transition — coordinators, documentation, adult metabolic physicians and funding.
  • Describe international transition models (France's 'Jump' and a US six-step system) and the principle that transition is a gradual, planned process.
  • Apply MPS-specific transition principles for cognitively intact and cognitively involved patients, keeping plans individualised and flexible.
Questions & Answers

Key questions

What is transition, and why does it matter in MPS?

Transition is a purposeful, planned process that addresses the medical, psychosocial and educational needs of adolescents as they move from child-centred to adult-oriented healthcare. It matters because treatment now lets many more children with MPS reach adulthood, so these 'childhood' diseases increasingly need adult physicians — and adolescence, already a turbulent stage, is made harder by a chronic, multisystem disease that requires lifelong care. Done poorly, patients fall into the gap between two very different care systems.

How do paediatric and adult care differ, and where do patients fall through?

Paediatric care is family-centred, holistic, protective and focused on development and growth; adult care emphasises independence, patient responsibility, and compartmentalised specialist input. Many providers in both — but especially in adult services — have limited training in adolescent medicine, so the adolescent group in between is poorly covered. Practical gaps include the loss of multidisciplinary, holistic coordination, less time for psychosocial needs, and adult settings less used to involving parents, whose expertise remains important.

What do European data show about the state of transition?

MetabERN surveys found major deficits: only about 11% of respondents were adult metabolic physicians, most centres are followed by paediatricians (often lifelong), and nearly 20% of patients never transition at all. There is a widespread lack of transition coordinators, no standardised written transition protocol in most places, a need for training in adolescent metabolic care, and a lack of financial support in around 90% of cases — with lack of time and of adult metabolic physicians the most cited reasons for not running a programme.

How should transition be approached in MPS?

As a gradual, planned, individualised process — not an event at 18 — ideally starting around age 12 and introducing adult services over several years, as in France's 'Jump' programme or the US six-step model. Two MPS groups need different approaches: cognitively intact patients working towards independence, work, relationships and family planning; and cognitively involved patients who depend on family, are sensitive to new environments, and need sustained support and end-of-life planning. Give young people time to be seen without their parents, appoint a coordinator, document the process, involve adult physicians before transfer and involve families throughout — keeping every plan flexible.